Literature DB >> 3244389

The relative potencies of cholinomimetics and muscarinic antagonists on the rat iris in vivo: effects of pH on potency of pirenzepine and telenzepine.

J J Hagan1, B van der Heijden, C L Broekkamp.   

Abstract

The effects of cholinomimetics and muscarinic antagonists were compared following topical administration to the eyes of anaesthetized rats. For tests with cholinomimetics, clonidine (0.3 mg/kg) was used to induce mydriasis via central inhibition of parasympathetic tone. Full, dose-dependent miosis was induced by acetylcholinesterase inhibitors [physostigmine greater than neostigmine greater than tetrahydroaminoacridine (THA)] and by membrane channel blockers (4-aminopyridine greater than 3,4-diaminopyridine). Oxotremorine was the most potent direct agonist tested [oxotremorine greater than arecaidine propargylester (APE) greater than arecoline greater than carbachol greater than ethoxyethyltrimethyl-ammonium iodide (EOE) greater than RS 86]. Some putative M1 selective agonists were weakly active or behaved as partial agonists (pilocarpine greater than AH6405 greater than Mc-A-343 greater than isoarecoline). Of the antagonists, compared in non-clonidine treated rats, scopolamine hydrochloride was the most potent. Of the receptor selective antagonists the M2 (ileal) selective compounds hexahydrosiladifenidol and 4-DAMP were more potent than either M1 selective (pirenzepine, telenzepine) or M2 (atrial) selective (AF DX 116) drugs. These data tentatively suggest the involvement of an M2 (ileal) type muscarinic receptor. Potency was lower for quaternary structures, probably due to impaired corneal penetration. The potency of pirenzepine and telenzepine was increased 60-fold at low pH following topical administration. Acid induced corneal damage does not appear to account for this potency shift as the effects of scopolamine and several agonists (oxotremorine, pilocarpine and McNA-343) were not substantially altered by acid media. For pirenzepine the potency shift appears to be related to protonation of the second amino group (N1) in the piperazine tail (pKa = 2.05).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3244389     DOI: 10.1007/bf00179317

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  34 in total

1.  Vehicle effects on ocular drug bioavailability II: Evaluation of pilocarpine.

Authors:  J W Sieg; J R Robinson
Journal:  J Pharm Sci       Date:  1977-09       Impact factor: 3.534

2.  Tricyclic compounds as selective antimuscarinics. 1. Structural requirements for selectivity toward the muscarinic acetylcholine receptor in a series of pirenzepine and imipramine analogues.

Authors:  W G Eberlein; G Trummlitz; W W Engel; G Schmidt; H Pelzer; N Mayer
Journal:  J Med Chem       Date:  1987-08       Impact factor: 7.446

3.  Mechanisms of corneal drug penetration. III: Modeling of molecular transport.

Authors:  G M Grass; E R Cooper; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

4.  Mechanisms of corneal drug penetration. II: Ultrastructural analysis of potential pathways for drug movement.

Authors:  G M Grass; J R Robinson
Journal:  J Pharm Sci       Date:  1988-01       Impact factor: 3.534

5.  Aminopyridines and synaptic transmission.

Authors:  S Thesleff
Journal:  Neuroscience       Date:  1980       Impact factor: 3.590

6.  The relative potencies of some agonists at M2 muscarinic receptors in guinea-pig ileum, atria and bronchi.

Authors:  R B Barlow; P Weston-Smith
Journal:  Br J Pharmacol       Date:  1985-06       Impact factor: 8.739

Review 7.  Pupillary dilation as an index of central nervous system alpha 2-adrenoceptor activation.

Authors:  M C Koss
Journal:  J Pharmacol Methods       Date:  1986-02

8.  Pirenzepine distinguishes between different subclasses of muscarinic receptors.

Authors:  R Hammer; C P Berrie; N J Birdsall; A S Burgen; E C Hulme
Journal:  Nature       Date:  1980-01-03       Impact factor: 49.962

9.  Pharmacological evidence for selective inhibition of gastric acid secretion by telenzepine, a new antimuscarinic drug.

Authors:  M Eltze; S Gönne; R Riedel; B Schlotke; C Schudt; W A Simon
Journal:  Eur J Pharmacol       Date:  1985-06-07       Impact factor: 4.432

10.  Dynamics of aminopyridine block of potassium channels in squid axon membrane.

Authors:  J Z Yeh; G S Oxford; C H Wu; T Narahashi
Journal:  J Gen Physiol       Date:  1976-11       Impact factor: 4.086

View more
  4 in total

1.  Different muscarine receptors mediate the prejunctional inhibition of [3H]-noradrenaline release in rat or guinea-pig iris and the contraction of the rabbit iris sphincter muscle.

Authors:  H Fuder; J Schöpf; J Unckell; M T Wesner; C Melchiorre; R Tacke; E Mutschler; G Lambrecht
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

2.  Multiple functional defects in peripheral autonomic organs in mice lacking muscarinic acetylcholine receptor gene for the M3 subtype.

Authors:  M Matsui; D Motomura; H Karasawa; T Fujikawa; J Jiang; Y Komiya; S Takahashi; M M Taketo
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Effects of disrupting the cholinergic system on short-term spatial memory in rats.

Authors:  J S Andrews; J H Jansen; S Linders; A Princen
Journal:  Psychopharmacology (Berl)       Date:  1994-08       Impact factor: 4.530

4.  Hemicholinium-3 impairs spatial learning and the deficit is reversed by cholinomimetics.

Authors:  J J Hagan; J H Jansen; C L Broekkamp
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.